Physician
Kamini Malhotra, M.D INC
Kamini Malhotra, M.D INC was paid $4.94M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 24% of everything it billed.
33Billing provider infoKAMINI MALHOTRA, M.D INC
FOUNTAIN VALLEY, CA 92708
FOUNTAIN VALLEY, CA 92708
33aNPI1023150182assigned 02/13/2007
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$4.94M
24GClaims867,617
24DCodes billed124
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#9 of 222
Median peer was paid$42K
This provider vs. median117×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 133,594 | $641K | |
| 2019 | 136,635 | $610K | |
| 2020 | 95,756 | $524K | |
| 2021 | 125,467 | $806K | |
| 2022 | 102,297 | $760K | |
| 2023 | 129,182 | $847K | |
| 2024incomplete | 144,686 | $755K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 24% | 22,535 | 21,627 | $1.20M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 9.5% | 12,328 | 11,280 | $472K |
| 88307 | 6.3% | 3,807 | 3,739 | $313K | |
| 88312 | 6.2% | 7,685 | 7,598 | $308K | |
| 88342 | 6.2% | 3,396 | 3,133 | $304K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.6% | 3,213 | 3,158 | $227K |
| 88304 | 4.6% | 8,031 | 7,966 | $226K | |
| 82962 | 4.5% | 39,131 | 11,438 | $224K | |
| 80053 | Comprehensive metabolic panel | 3.7% | 93,161 | 47,082 | $182K |
| 88341 | 2.7% | 1,185 | 1,057 | $136K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 87,638 | 43,841 | $129K |
| 88313 | 1.9% | 2,242 | 2,222 | $93K |
112 more codes
| 83880 | 1.8% | 14,056 | $88K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.8% | 1,978 | $88K |
| 85027 | 1.6% | 64,395 | $80K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 46,340 | $72K |
| 83735 | 1.2% | 42,294 | $60K | |
| 88112 | 1.1% | 1,899 | $57K | |
| 84484 | 1.1% | 24,125 | $55K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,267 | $41K |
| 87040 | <1% | 13,210 | $40K | |
| 83690 | <1% | 24,137 | $31K | |
| 84145 | <1% | 5,928 | $28K | |
| 83605 | <1% | 11,915 | $27K | |
| 81001 | <1% | 43,449 | $27K | |
| 85610 | <1% | 30,958 | $26K | |
| 88331 | <1% | 388 | $22K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,776 | $21K |
| 84100 | <1% | 22,174 | $20K | |
| 88302 | <1% | 768 | $20K | |
| 85730 | <1% | 15,373 | $19K | |
| 87081 | <1% | 12,167 | $18K | |
| 87088 | <1% | 13,280 | $17K | |
| 87077 | <1% | 7,634 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,700 | $16K |
| 80076 | <1% | 10,408 | $15K | |
| 80061 | Lipid panel | <1% | 5,069 | $12K |
| 88300 | <1% | 1,619 | $12K | |
| 87070 | <1% | 6,158 | $10K | |
| 85379 | <1% | 4,698 | $9K | |
| 82728 | <1% | 3,551 | $9K | |
| 86140 | <1% | 9,294 | $9K | |
| 87186 | <1% | 4,771 | $9K | |
| 86901 | <1% | 15,508 | $8K | |
| 86900 | <1% | 14,916 | $8K | |
| 87400 | <1% | 5,808 | $8K | |
| 82140 | <1% | 2,748 | $7K | |
| 81025 | <1% | 4,226 | $7K | |
| 86850 | <1% | 10,393 | $6K | |
| 80320 | <1% | 2,279 | $6K | |
| 82550 | <1% | 4,543 | $5K | |
| 84439 | <1% | 3,307 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 180 | $5K |
| 83615 | <1% | 4,771 | $5K | |
| 80074 | <1% | 656 | $5K | |
| 84702 | <1% | 1,672 | $4K | |
| 82607 | <1% | 1,365 | $4K | |
| 86880 | <1% | 3,457 | $4K | |
| 85384 | <1% | 1,749 | $4K | |
| 82746 | <1% | 1,363 | $4K | |
| 85014 | <1% | 5,125 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 140 | $3K |
| 87430 | <1% | 1,888 | $3K | |
| 85007 | <1% | 4,959 | $3K | |
| 82948 | <1% | 3,117 | $3K | |
| 80305 | <1% | 249 | $3K | |
| 83550 | <1% | 1,729 | $3K | |
| 80047 | <1% | 1,394 | $2K | |
| 84550 | <1% | 2,548 | $2K | |
| 83540 | <1% | 1,730 | $2K | |
| 81003 | <1% | 3,640 | $2K | |
| 87075 | <1% | 928 | $2K | |
| 82533 | <1% | 590 | $2K | |
| 87205 | <1% | 1,934 | $2K | |
| 82105 | <1% | 160 | $2K | |
| 88108 | <1% | 39 | $1K | |
| 80202 | <1% | 652 | $1K | |
| 87116 | <1% | 567 | $1K | |
| 85651 | <1% | 2,160 | $1K | |
| 82570 | <1% | 1,191 | $1K | |
| 85652 | <1% | 2,254 | $1K | |
| 80329 | <1% | 296 | $1K | |
| 85060 | <1% | 128 | $1K | |
| 84703 | <1% | 743 | $992.29 | |
| 87102 | <1% | 542 | $904.42 | |
| 84134 | <1% | 295 | $902.95 | |
| 88141 | <1% | 71 | $746.58 | |
| 87206 | <1% | 586 | $738.50 | |
| 84300 | <1% | 734 | $687.34 | |
| 87324 | <1% | 296 | $621.87 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 581 | $619.71 |
| 82378 | <1% | 158 | $541.28 | |
| 86920 | <1% | 140 | $522.00 | |
| 88311 | <1% | 97 | $519.35 | |
| 84156 | <1% | 796 | $513.42 | |
| 82803 | <1% | 207 | $495.87 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 124 | $446.75 |
| 87420 | <1% | 662 | $416.95 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 212 | $363.09 |
| 87147 | <1% | 297 | $315.56 | |
| 86301 | <1% | 105 | $305.67 | |
| 85018 | <1% | 296 | $300.07 | |
| 87106 | <1% | 125 | $194.50 | |
| 87210 | <1% | 203 | $189.33 | |
| 87149 | <1% | 63 | $178.52 | |
| 85045 | <1% | 208 | $130.85 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 32 | $124.14 |
| 85347 | <1% | 41 | $109.16 | |
| 82553 | <1% | 29 | $85.00 | |
| 89050 | <1% | 25 | $78.21 | |
| 83874 | <1% | 56 | $73.91 | |
| 83970 | <1% | 12 | $73.65 | |
| 84481 | <1% | 31 | $72.32 | |
| 86592 | <1% | 112 | $58.53 | |
| 82272 | <1% | 55 | $57.16 | |
| 83935 | <1% | 37 | $55.42 | |
| 85520 | <1% | 31 | $48.09 | |
| 87449 | <1% | 26 | $42.74 | |
| 82150 | <1% | 25 | $31.92 | |
| 87015 | <1% | 18 | $28.95 | |
| 85380 | <1% | 16 | $13.09 | |
| 82945 | <1% | 16 | $12.24 | |
| 83721 | <1% | 12 | $10.95 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALHOTRA, KAMINI (PRESIDENT)
Parent organizationKAMINI MALHOTRA, M.D INC